Calian Group (TSE:CGY) Price Target Raised to C$76.00

Calian Group (TSE:CGY) had its target price lifted by Canadian Imperial Bank of Commerce from C$65.00 to C$76.00 in a report issued on Friday morning,BayStreet.CA reports.

A number of other brokerages also recently issued reports on CGY. Ventum Financial raised their price objective on Calian Group from C$62.00 to C$72.00 and gave the stock a “buy” rating in a research report on Tuesday, January 27th. Royal Bank Of Canada increased their target price on shares of Calian Group from C$58.00 to C$66.00 and gave the company an “outperform” rating in a research report on Thursday, November 27th. Canaccord Genuity Group raised their price target on shares of Calian Group from C$60.00 to C$63.00 and gave the stock a “buy” rating in a report on Thursday, November 27th. Finally, Desjardins boosted their price target on shares of Calian Group from C$59.00 to C$66.00 and gave the stock a “buy” rating in a research report on Thursday, November 27th. Six equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of C$74.83.

Calian Group Price Performance

Shares of TSE:CGY opened at C$70.60 on Friday. The company has a debt-to-equity ratio of 39.54, a quick ratio of 1.20 and a current ratio of 1.29. Calian Group has a 52 week low of C$37.70 and a 52 week high of C$71.92. The firm has a market cap of C$805.62 million, a PE ratio of 30.96, a price-to-earnings-growth ratio of 2.50 and a beta of 0.70. The firm’s fifty day moving average is C$60.38 and its 200-day moving average is C$54.15.

Calian Group (TSE:CGY) last announced its earnings results on Thursday, February 12th. The company reported C$1.03 earnings per share (EPS) for the quarter. The business had revenue of C$208.00 million during the quarter. Calian Group had a return on equity of 3.37% and a net margin of 1.50%. Sell-side analysts predict that Calian Group will post 4.9475219 earnings per share for the current year.

Calian Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 11th. Shareholders of record on Wednesday, March 11th will be issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Wednesday, February 25th. Calian Group’s dividend payout ratio is presently 49.12%.

More Calian Group News

Here are the key news stories impacting Calian Group this week:

• Positive Sentiment: Record Q1 results — Calian reported C$208M revenue (up ~12% YoY) with margin gains and C$1.03 EPS, and management signaled confident growth on the earnings call; this strengthens the growth narrative driving buying interest. Calian Delivers Record Q1 Revenue and Margin Gains
• Positive Sentiment: Multiple analyst target upgrades — Acumen (to C$85, Buy), Canaccord (to C$80), CIBC (to C$76) and Ventum (to C$82, Buy) raised price targets, signaling broad analyst optimism and providing upward catalyst for the stock. Analyst Ratings Roundup
• Positive Sentiment: Quarterly dividend declared — Board approved a C$0.28 quarterly dividend (annualized yield ~1.6%), with ex-dividend Feb 25 and record Mar 11; supports shareholder return profile and can attract income-minded buyers.
• Neutral Sentiment: Corporate governance update — Shareholders re‑elected the board and named Valerie Sorbie as Chair, which preserves leadership continuity but is unlikely to move the stock materially by itself. Shareholder Meeting Results
• Negative Sentiment: RBC’s moderate target bump to C$60 — Although RBC maintained an “outperform” stance, its target remains well below the current price, indicating at least one major analyst sees less upside and creating potential resistance or caution among some investors. RBC Target Update

About Calian Group

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.